Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0001415889-22-002936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-14 | 2022-03-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,253 | 7,711 | +214% | +$10.8K |
| D | 2022-03-14 | 2022-03-10 | OLMA | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $4.75 | -5,253 | 2,458 | -68% | -$25.0K |
| D | 2022-03-14 | 2022-03-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $0.00 | -5,253 | 141.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 5,253 | $2.06 | 7,711 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-10 | S | D | 5,253 | $4.75 | 2,458 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-10 | M | D | 5,253 | $0.00 | 141,785 | D | $2.06 · — to 2030-06-10 | 5,253 Common Stock | (F2) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. |